Article Details

Lilly's $6.5B AAPI Facility: Strategic Catalyst for Long-Term Value and Supply Chain Resilience

Retrieved on: 2025-09-23 18:03:50

Tags for this article:

Click the tags to see associated articles and topics

Lilly's $6.5B AAPI Facility: Strategic Catalyst for Long-Term Value and Supply Chain Resilience. View article details on hiswai:

Excerpt

... antibody-drug conjugates (ADCs) and monoclonal antibodies for oncology, autoimmune diseases, and other advanced therapies Lilly announces plans to ...

Article found on: www.ainvest.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo